Compounds of Formula I, pharmaceutically acceptable salts thereof, tautomers thereof, pharmaceutically acceptable salts of the tautomers, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula (I) have the following structure: where the definitions of the variables are provided herein.
式 I 的化合物、其药学上可接受的盐、其同系物、同系物的药学上可接受的盐或其混合物是 APJ 受体的激动剂,可用于治疗心血管疾病和其他疾病。式(I)化合物具有如下结构: 其中变量的定义在本文中提供。
FUSED TRIAZOLE AGONISTS OF THE APJ RECEPTOR
申请人:AMGEN INC.
公开号:US20200308189A1
公开(公告)日:2020-10-01
Compounds of Formula I, pharmaceutically acceptable salts thereof, tautomers thereof, pharmaceutically acceptable salts of the tautomers, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula (I) have the following structure: where the definitions of the variables are provided herein.